Method for silk fibroin gelation using sonication
This invention provides for a process of rapidly forming silk fibroin gelation through ultrasonication. Under the appropriate conditions, gelation can be controlled to occur within two hours after the ultrasonication treatment. Biological materials, including viable cells, or therapeutic agents can be encapsulated in the hydrogels formed from the process and be used as delivery vehicles.
1. A process of rapidly forming silk fibroin gelation, the process comprising:
exposing an aqueous silk fibroin solution to a treatment comprising ultrasonication for a period of about 5 seconds to about 60 seconds to initiate gelation,
wherein the power output of ultrasonication ranges from about 10% to about 50% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof.
2. The process of claim 1 , wherein the silk fibroin gelation forms less than two hours after the ultrasonication treatment.
3. The process of claim 1 , wherein the aqueous silk fibroin solution further comprises a salt.
4. The process of claim 3 , wherein the salt comprises ions selected from the group consisting of potassium, calcium, sodium, magnesium, copper, zinc, and combinations thereof.
5. The process of claim 4 , wherein the salt is potassium, and the salt concentration is less than 100 mM.
6. A method of encapsulating at least one agent in silk fibroin, comprising:
(i)
a. contacting an aqueous silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein the power output of ultrasonication ranges from about 10% to about 50% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof; and
b. introducing the agent(s) to the silk fibroin solution before substantial gelation occurs in the silk fibroin solution,
thereby forming a silk-fibroin encapsulated agent; or
(ii)
a. introducing the agent(s) to an aqueous silk fibroin solution; and
b. contacting the silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein the power output of ultrasonication ranges from about 10% to about 50% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof,
thereby forming a silk-fibroin encapsulated agent.
7. The method of claim 6 , wherein the agent is a therapeutic agent or a biological material, or both.
8. The method of claim 6 , wherein the agent is selected from the group consisting of cells, proteins, peptides, nucleic acids, PNA, aptamers, antibodies, hormones, growth factors, cytokines, enzymes, antimicrobial compounds, small molecules, drugs, and combinations thereof.
9. The method of claim 8 , wherein said cell is a stem cell.
10. The method of claim 7 , wherein a cell growth medium is introduced into silk fibroin solution with the biological material.
11. The method of claim 6 , wherein the silk-fibroin encapsulated biological material is suitable for a biodelivery device.
12. A process of rapidly forming silk fibroin gelation, the process comprising:
exposing an aqueous silk fibroin solution to a treatment comprising ultrasonication for a period of about 5 seconds to about 60 seconds to initiate gelation,
wherein the power output of ultrasonication ranges from about 25% to about 55% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof.
13. The process of claim 12 , wherein the silk fibroin gelation forms less than two hours after the ultrasonication treatment.
14. A method of encapsulating at least one agent in silk fibroin, comprising:
(i)
a. contacting an aqueous silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein the power output of ultrasonication ranges from about 25% to about 55% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof; and
b. introducing the agent(s) to the silk fibroin solution before substantial gelation occurs in the silk fibroin solution,
thereby forming a silk-fibroin encapsulated agent; or
(ii)
a. introducing the agent(s) to an aqueous silk fibroin solution; and
b. contacting the silk fibroin solution with an ultrasonication treatment for a period of about 5 seconds to about 60 seconds to initiate gelation, wherein the power output of ultrasonication ranges from about 25% to about 55% amplitude, and wherein the silk fibroin is selected from the group consisting of silk produced by silkworms, silk produced by spiders and variants thereof,
thereby forming a silk-fibroin encapsulated agent.
15. The method of claim 14 , wherein the agent is a therapeutic agent or a biological material, or both.
16. The method of claim 14 , wherein the agent is selected from the group consisting of cells, proteins, peptides, nucleic acids, PNA, aptamers, antibodies, hormones, growth factors, cytokines, enzymes, antimicrobial compounds, small molecules, drugs, and combinations thereof.